Ignite Creation Date:
2024-05-06 @ 8:21 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02729025
Status:
COMPLETED
Last Update Posted:
2022-09-23
First Post:
2016-03-08
Brief Title:
Effects of Proprotein Convertase SubtilisinKexin Type 9 PCSK9 Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoproteina Lpa
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20130293
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None